{"DataElement":{"publicId":"6061810","version":"1","preferredName":"BRAF Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of BRAF gene mutant protein identified.","longName":"BRAF_mutation","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6060297","version":"1","preferredName":"BRAF Gene Mutant Protein Identification","preferredDefinition":"This gene is involved in cell organization/biogenesis and the inhibition of apoptosis._A protein with an amino acid sequence that differs from the wildtype, canonical sequence._The procedure of having an identity established.","longName":"3107133v1.0:6101599v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"3107133","version":"1","preferredName":"BRAF Gene","preferredDefinition":"This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.","longName":"C18363","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRAF Gene","conceptCode":"C18363","definition":"This gene is involved in cell organization/biogenesis and the inhibition of apoptosis.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"883834AB-1259-C6A6-E040-BB89AD431A8D","latestVersionIndicator":"Yes","beginDate":"2010-06-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-04","modifiedBy":"ONEDATA","dateModified":"2010-06-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6101599","version":"1","preferredName":"Mutant Protein Identification","preferredDefinition":"A protein with an amino acid sequence that differs from the wildtype, canonical sequence.:The procedure of having an identity established.","longName":"C147118:C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutant Protein","conceptCode":"C147118","definition":"A protein with an amino acid sequence that differs from the wildtype, canonical sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ABA3FA-C72E-36DE-E053-F662850A178D","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"ONEDATA","dateModified":"2018-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"647DA9BD-9648-0B6B-E053-F662850A5B7F","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6061802","version":"1","preferredName":"BRAF Protein Variant Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6061802v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other (specify)","valueDescription":"Specify Other","ValueMeaning":{"publicId":"2770998","version":"1","preferredName":"Specify Other","longName":"2770998","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F45DBF-5E42-1D6F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-08-08","modifiedBy":"COOPERM","dateModified":"2018-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"648DAFC3-B428-7875-E053-F662850A9289","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":"K601E","valueDescription":"BRAF NP_004324.2:p.K601E ","ValueMeaning":{"publicId":"6061803","version":"1","preferredName":"BRAF NP_004324.2:p.K601E ","longName":"6061803","preferredDefinition":"A change in the amino acid residue at position 601 in the serine/threonine protein kinase B-raf protein where lysine has been replaced by glutamic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRAF NP_004324.2:p.K601E","conceptCode":"C146881","definition":"A change in the amino acid residue at position 601 in the serine/threonine protein kinase B-raf protein where lysine has been replaced by glutamic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"648DAFC3-B433-7875-E053-F662850A9289","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"648DAFC3-B44C-7875-E053-F662850A9289","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":"V600R","valueDescription":"BRAF NP_004324.2:p.V600R","ValueMeaning":{"publicId":"3589870","version":"1","preferredName":"BRAF NP_004324.2:p.V600R","longName":"3589870","preferredDefinition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by arginine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRAF NP_004324.2:p.V600R","conceptCode":"C98353","definition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by arginine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C9FC0688-6D81-BC7C-E040-BB89AD431DF5","latestVersionIndicator":"Yes","beginDate":"2012-09-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-09-18","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"648DAFC3-B460-7875-E053-F662850A9289","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":"V600K","valueDescription":"BRAF NP_004324.2:p.V600K","ValueMeaning":{"publicId":"6061804","version":"1","preferredName":"BRAF NP_004324.2:p.V600K","longName":"6061804","preferredDefinition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by lysine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRAF NP_004324.2:p.V600K","conceptCode":"C98347","definition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by lysine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"648DAFC3-B46D-7875-E053-F662850A9289","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"648DAFC3-B486-7875-E053-F662850A9289","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":"V600D","valueDescription":"BRAF NP_004324.2:p.V600D","ValueMeaning":{"publicId":"3540174","version":"1","preferredName":"BRAF NP_004324.2:p.V600D","longName":"3540174","preferredDefinition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by aspartic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRAF NP_004324.2:p.V600D","conceptCode":"C98340","definition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by aspartic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C64B7AB4-7525-3222-E040-BB89AD434936","latestVersionIndicator":"Yes","beginDate":"2012-08-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-08-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"648DAFC3-B49A-7875-E053-F662850A9289","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"},{"value":"V600E","valueDescription":"BRAF NP_004324.2:p.V600E","ValueMeaning":{"publicId":"3536308","version":"1","preferredName":"BRAF NP_004324.2:p.V600E","longName":"3536308","preferredDefinition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by glutamic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BRAF NP_004324.2:p.V600E","conceptCode":"C98342","definition":"A change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by glutamic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C5D686D5-F5DC-76D9-E040-BB89AD433B31","latestVersionIndicator":"Yes","beginDate":"2012-07-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-27","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"648DAFC3-B4AF-7875-E053-F662850A9289","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"ONEDATA","dateModified":"2018-02-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648DAFC3-B407-7875-E053-F662850A9289","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000192","version":"1","longName":"Colorectal","context":"OCG"},{"publicId":"10000448","version":"1","longName":"Melanoma","context":"OCG"},{"publicId":"10000003","version":"1","longName":"Lung","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If BRAF mutation identified,","type":"Preferred Question Text","description":"If BRAF mutation identified, which one?","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"648D5A58-9680-09BF-E053-F662850A213A","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-06","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}